Photo taken from EGFR Positive Lung Cancer UK/X
Aug 21, 2024, 20:04
EGFR Positive Lung Cancer’s survey deadline extended to 31 August
EGFR Positive Lung Cancer UK shared a post on X:
“We need MORE EGFR+ lung cancer pts on TKIs/targeted trmts to share experiences with side effects.
We’ve extended our survey deadline to 31 Aug. for the fantastic response so far.
Your input will help us deliver impactful insights at ESMO and beyond.”
Source: EGFR Positive Lung Cancer UK/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 2, 2025, 21:49
Jan 2, 2025, 21:49
Jan 2, 2025, 21:47
Jan 2, 2025, 20:36